A Hybrid Vector for Ligand-Directed Tumor Targeting and Molecular Imaging

Cell

Volumn 125, Issue 2, 2006, Pages 385-398

  Hajitou, Amin ^a   Trepel, Martin ^b   Lilley, Caroline E ^c   Soghomonyan, Suren ^a   Alauddin, Mian M ^a   Marini III, Frank C ^a   Restel, Bradley H ^a   Ozawa, Michael G ^a   Moya, Catherine A ^a   Rangel, Roberto ^a   Sun, Yan ^a   Zaoui, Karim ^b   Schmidt, Manfred ^b   von Kalle, Christof ^b   Weitzman, Matthew D ^c   Gelovani, Juri G ^a   Pasqualini, Renata ^a   Arap, Wadih ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF FREIBURG   (Germany)

^c SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIOPHAGE; CANCER GENETICS; CHIMERA; CONTROLLED STUDY; EVALUATION; GENE TARGETING; GENETIC ANALYSIS; HUMAN; HUMAN CELL; LIGAND BINDING; MAMMAL CELL; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROKARYOTE; TRANSGENE; VIRUS PARTICLE;

ADENO-ASSOCIATED VIRUS; ANIMALIA; EUKARYOTA; MAMMALIA; PROKARYOTA;

EID: 33646034578     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2006.02.042     Document Type: Article

References (45)

1. 18F]fluoro-5-methyl-1-β-D-arabinofuranosyluracil and its 5-substituted nucleosides. J. Labelled Comp. Radiopharm. 46 (2003) 285-289
2. Arap W., Pasqualini R., and Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279 (1998) 377-380
3. Arap W., Kolonin M.G., Trepel M., Lahdenranta J., Cardó-Vila M., Giordano R.J., Mintz P.J., Ardelt P.U., Yao V.J., Vidal C.I., et al. Steps toward mapping the human vasculature by phage display. Nat. Med. 8 (2002) 121-127
4. Arap M.A., Lahdenranta J., Mintz P.J., Hajitou A., Sarkis A.S., Arap W., and Pasqualini R. Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands. Cancer Cell 6 (2004) 275-284
5. Barbas III C.F., Burton D.R., Scott J.K., and Silverman G.J. Phage Display: A Laboratory Manual (2001), Cold Spring Harbor Press, New York
6. Barrow P.A., and Soothill J.S. Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential. Trends Microbiol. 5 (1997) 268-271
7. Blasberg R.G., and Tjuvajev J.G. Molecular-genetic imaging: current and future perspectives. J. Clin. Invest. 111 (2003) 1620-1629
8. Chen L., Zurita A.J., Ardelt P.U., Giordano R.J., Arap W., and Pasqualini R. Design and validation of a bifunctional ligand display system for receptor targeting. Chem. Biol. 11 (2004) 1081-1091
9. De A., and Gambhir S.S. Noninvasive imaging of protein-protein interactions from live cells and living subjects using bioluminescence resonance energy transfer. FASEB J. 19 (2005) 2017-2019
10. Ellerby H.M., Arap W., Ellerby L.M., Kain R., Andrusiak R., Rio G.D., Krajewski S., Lombardo C.R., Rao R., Ruoslahti E., et al. Anti-cancer activity of targeted pro-apoptotic peptides. Nat. Med. 5 (1999) 1032-1038
11. Geier M.R., Trigg M.E., and Merill C.R. Fate of bacteriophage lambda in non-immune germ-free mice. Nature 246 (1973) 221-223
12. Gelovani Tjuvajev J., and Blasberg R.G. In vivo imaging of molecular-genetic targets for cancer therapy. Cancer Cell 3 (2003) 327-332
13. Giordano R.J., Cardó-Vila M., Lahdenranta J., Pasqualini R., and Arap W. Biopanning and rapid analysis of selective interactive ligands. Nat. Med. 11 (2001) 1249-1253
14. Gross S., and Piwnica-Worms D. Spying on cancer: molecular imaging in vivo with genetically encoded reporters. Cancer Cell 7 (2005) 5-15
15. Gross S., and Piwnica-Worms D. Monitoring proteasome activity in cellulo and in living animals by bioluminescent imaging: technical considerations for design and use of genetically encoded reporters. Methods Enzymol. 399 (2005) 512-530
16. Hajitou A., Sounni N.E., Devy L., Grignet-Debrus C., Lewalle J.M., Li H., Deroanne C.F., Lu H., Colige A., Nusgens B.V., et al. Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis. Cancer Res. 61 (2001) 3450-3457
17. Hajitou A., Pasqualini R., and Arap W. Vascular targeting: recent advances and therapeutic perspectives. Trends Cardiovasc. Med. 16 (2006) 80-88
18. Hood J.D., Bednarski M., Frausto R., Guccione S., Reisfeld R.A., Xiang R., and Cheresh D.A. Tumor regression by targeted gene delivery to the neovasculature. Science 296 (2002) 2404-2407
19. Hsiao C.D., Hsieh F.J., and Tsai H.J. Enhanced expression and stable transmission of transgenes flanked by inverted terminal repeats from adeno-associated virus in zebrafish. Dev. Dyn. 220 (2001) 323-336
20. Ivanenkov V.V., Felici F., and Menon A.G. Targeted delivery of multivalent phage display vectors into mammalian cells. Biochim. Biophys. Acta 1448 (1999) 463-472
21. 3H]PCV for monitoring reporter gene expression of wild type and mutant Herpes simplex virus type 1 thymidine kinase in cell culture. Mol. Imaging Biol. 7 (2005) 296-303
22. Kootstra N.A., and Verma I.M. Gene therapy with viral vectors. Annu. Rev. Pharmacol. Toxicol. 43 (2003) 413-439
23. Larocca D., Kassner P.D., Witte A., Ladner R.C., Pierce G.F., and Baird A. Gene transfer to mammalian cells using genetically targeted filamentous bacteriophage. FASEB J. 13 (1999) 727-734
24. Lieber A., Steinwaerder D.S., Carlson C.A., and Kay M.A. Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes. J. Virol. 73 (1999) 9314-9324
25. Luker K.E., Smith M.C., Luker G.D., Gammon S.T., Piwnica-Worms H., and Piwnica-Worms D. Kinetics of regulated protein-protein interactions revealed with firefly luciferase complementation imaging in cells and living animals. Proc. Natl. Acad. Sci. USA 101 (2004) 12288-12293
26. Marchiò S., Lahdenranta J., Schlingemann R.O., Valdembri D., Wesseling P., Arap M.A., Hajitou A., Ozawa M.G., Trepel M., Giordano R.J., et al. Aminopeptidase A is a functional target in angiogenic blood vessels. Cancer Cell 5 (2004) 151-162
27. Massoud T.F., and Gambhir S.S. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev. 17 (2003) 545-580
28. McCarty D.M., Young Jr. S.M., and Samulski R.J. Integration of adeno-associated virus (AAV) and recombinant AAV vectors. Annu. Rev. Genet. 38 (2004) 819-845
29. Medintz I.L., Uyeda H.T., Goldman E.R., and Mattoussi H. Quantum dot bioconjugates for imaging, labelling and sensing. Nat. Mater. 6 (2005) 435-446
30. Mizuguchi H., and Hayakawa T. Targeted adenovirus vectors. Hum. Gene Ther. 15 (2004) 1034-1044
31. Müller O.J., Kaul F., Weitzman M.D., Pasqualini R., Arap W., Kleinschmidt J.A., and Trepel M. Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors. Nat. Biotechnol. 21 (2003) 1040-1046
32. Pasqualini R., Koivunen E., and Ruoslahti E. Alpha v integrins as receptors for tumor targeting by circulating ligands. Nat. Biotechnol. 15 (1997) 542-546
33. Pentz R.D., Cohen C.B., Wicclair M., Devita M.A., Flamm A.L., Youngner S.J., Hamric A.B., McCabe M.S., Glover J.J., Kittiko W.J., et al. Ethics guidelines for research with the recently dead. Nat. Med. 11 (2005) 1145-1149
34. Piersanti S., Cherubini G., Martina Y., Salone B., Avitabile D., Grosso F., Cundari E., Di Zenzo G., and Saggio I. Mammalian cell transduction and internalization properties of lambda phages displaying the full-length adenoviral penton base or its central domain. J. Mol. Med. 82 (2004) 467-476
35. Poul M.A., and Marks J.D. Targeted gene delivery to mammalian cells by filamentous bacteriophage. J. Mol. Biol. 288 (1999) 203-211
36. Ray P., Bauer E., Iyer M., Barrio J.R., Satyamurthy N., Phelps M.E., Herschman H.R., and Gambhir S.S. Monitoring gene therapy with reporter gene imaging. Semin. Nucleic Med. 31 (2001) 312-320
37. Smith G.P., and Scott J.K. Libraries of peptides and proteins displayed on filamentous phage. Methods Enzymol. 217 (1993) 228-257
38. Souza G.R., Christianson D.R., Staquicini F.I., Ozawa M.G., Snyder E.Y., Sidman R.L., Miller H.L., Arap W., and Pasqualini R. Networks of gold nanoparticles and bacteriophage as biological sensors and cell targeting agents. Proc. Natl. Acad. Sci. USA 103 (2006) 1215-1220
39. Tai Y.C., and Laforest R. Instrumentation aspects of animal PET. Annu. Rev. Biomed. Eng. 7 (2005) 255-285
40. Tjuvajev J.G., Avril N., Oku T., Sasajima T., Miyagawa T., Joshi R., Safer M., Beattie B., DiResta G., Daghighian F., et al. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res. 58 (1998) 4333-4341
41. Tjuvajev J.G., Chen S.H., Joshi A., Joshi R., Guo Z.S., Balatoni J., Ballon D., Koutcher J., Finn R., Woo S.L., et al. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo. Cancer Res. 59 (1999) 5186-5193
42. Trepel M., Arap W., and Pasqualini R. Modulation of the immune response by systemic targeting of antigens to lymph nodes. Cancer Res. 61 (2001) 8110-8112
43. Xiao X., Li J., and Samulski R.J. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 72 (1998) 2224-2232
44. Yang C.C., Xiao X., Zhu X., Ansardi D.C., Epstein N.D., Frey M.R., Matera A.G., and Samulski R.J. Cellular recombination pathways and viral terminal repeat hairpin structures are sufficient for adeno-associated virus integration in vivo and in vitro. J. Virol. 71 (1997) 9231-9247
45. Zacher III A.N., Stock C.A., Golden II J.W., and Smith G.P. A new filamentous phage cloning vector: fd-tet. Gene 9 (1980) 127-140